Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Auto Added by WPeMatico
Chip designer Arm previewed new innovations in its AI compute portfolio spanning data centers to edge devices. The post Arm Extends AI Reach From Data Centers To Edge Devices appeared first on Investor’s Business Daily.
Novartis said late Friday its Ionis-partnered Lp(a) blocker failed in testing. The results sent Novartis and Ionis stocks tumbling. The post Novartis, Ionis Tumble On Surprise Flop For Heart Drug appeared first on Investor’s Business Daily.
Oracle stock climbed for a third consecutive day Friday as the enterprise technology giant prepares to release its earnings. The post Oracle Stock Climbs Ahead Of Earnings After OpenAI Astra Release appeared first on Investor’s Business Daily.
Apple on Wednesday is widely expected to introduce its iPhone 18 handsets, including its first folding-screen model. The post Apple Poised To Unveil Folding iPhone appeared first on Investor’s Business Daily.
Zscaler stock fell amid fiscal Q4 earnings that topped estimates while the outlook for a key metric in fiscal 2027 underwhelmed. The post Zscaler Dips On Fiscal 2027 Outlook For Key Sales Metric appeared first on Investor’s Business Daily.
Samsara stock popped amid Q2 earnings and revenue topped estimates while the company’s October-quarter revenue guidance came in above views. The post Samsara Earnings, Revenue, Outlook Top Consensus Estimates appeared first on Investor’s Business Daily.
Zscaler stock popped amid fiscal Q4 earnings that topped estimates while October quarter guidance came in above views. The post Zscaler Stock Wavers On Cybersecurity Firm’s Earnings Beat, Outlook appeared first on Investor’s Business Daily.
Ambarella narrowly beat estimates for its fiscal second quarter and matched views with its sales forecast for fiscal Q3. AMBA stock wavered in extended trading. The post Chipmaker Ambarella Posts Mixed Fiscal Q2 Earnings Report appeared first on Investor’s Business…
Summit Therapeutics stock rocketed Thursday after its experimental cancer drug outperformed Merck’s blockbuster, Keytruda. The post Summit Packs A Punch For Merck’s Keytruda — But Not Everyone Is Sold appeared first on Investor’s Business Daily.
Broadcom expects its artificial intelligence-related sales to double next year and again the following year. Broadcom stock fell Thursday. The post Broadcom Forecasts Steep Ramp In AI Revenue appeared first on Investor’s Business Daily.
